• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T4N0M0(直径≥7cm)非小细胞肺癌中的肿瘤内遗传和免疫微环境异质性。

Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers.

机构信息

The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

出版信息

Thorac Cancer. 2022 May;13(9):1333-1341. doi: 10.1111/1759-7714.14393. Epub 2022 Apr 8.

DOI:10.1111/1759-7714.14393
PMID:35394115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9058296/
Abstract

BACKGROUND

Starting with low metastatic capability, T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers (NSCLCs) constitute a unique tumor subset, as with a large tumor size but no regional or distant metastases. We systematically investigated intratumoral heterogeneity, clonal structure, chromosomal instability (CIN), and immune microenvironment in T4N0M0 (≥7 cm) NSCLCs.

METHODS

Whole-exome sequencing, RNA sequencing, and multiplex immunohistochemistry (mIHC) staining were conducted to analyze 24 spatially segregated tumor samples from eight patients who were pathologically diagnosed with T4N0M0 (diameter ≥ 7 cm) NSCLCs. The adjacent normal tissues and peripheral blood served as controls.

RESULTS

In total, 35.2% of mutations and 91.1% of somatic copy number alterations were classified as subclonal events, which exhibited widespread genetic intratumoral heterogeneity. In contrast, a low degree of CIN was observed. None of the patients had genome doubling. The burden of loss of heterozygosity, aneuploidy, and the genome instability index of these tumors were significantly lower than those in the TRACERx cohort. Expression profiles revealed significantly upregulated expression of cell division-related signals and the G2/M checkpoint pathway. In addition, a similar expression pattern of the immune microenvironment was observed in different regions of the tumor, which was confirmed by mIHC profiles.

CONCLUSIONS

Our study indicates the presence of intratumoral genetic heterogeneity and immune microenvironmental heterogeneity features in T4N0M0 NSCLCs, and the low degree of CIN may be related to the low metastatic capability.

摘要

背景

从低转移性能力开始,T4N0M0(直径≥7cm)非小细胞肺癌(NSCLC)构成了一个独特的肿瘤亚群,因为肿瘤体积大,但没有局部或远处转移。我们系统地研究了 T4N0M0(≥7cm)NSCLC 中的肿瘤内异质性、克隆结构、染色体不稳定性(CIN)和免疫微环境。

方法

对 8 名病理诊断为 T4N0M0(直径≥7cm)NSCLC 的患者的 24 个空间分离的肿瘤样本进行了全外显子组测序、RNA 测序和多重免疫组化(mIHC)染色。相邻的正常组织和外周血作为对照。

结果

共有 35.2%的突变和 91.1%的体细胞拷贝数改变被归类为亚克隆事件,表现出广泛的肿瘤内遗传异质性。相反,观察到低度 CIN。没有患者发生基因组倍增。这些肿瘤的杂合性缺失负担、非整倍体和基因组不稳定性指数明显低于 TRACERx 队列。表达谱显示细胞分裂相关信号和 G2/M 检查点途径的表达显著上调。此外,不同肿瘤区域的免疫微环境表达模式相似,这通过 mIHC 谱得到了证实。

结论

我们的研究表明,T4N0M0 NSCLC 存在肿瘤内遗传异质性和免疫微环境异质性特征,低度 CIN 可能与低转移性能力有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/476111e3582d/TCA-13-1333-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/2d4ca45c9459/TCA-13-1333-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/5f1132df7716/TCA-13-1333-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/55e8020b03e5/TCA-13-1333-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/476111e3582d/TCA-13-1333-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/2d4ca45c9459/TCA-13-1333-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/5f1132df7716/TCA-13-1333-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/55e8020b03e5/TCA-13-1333-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a265/9058296/476111e3582d/TCA-13-1333-g001.jpg

相似文献

1
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers.T4N0M0(直径≥7cm)非小细胞肺癌中的肿瘤内遗传和免疫微环境异质性。
Thorac Cancer. 2022 May;13(9):1333-1341. doi: 10.1111/1759-7714.14393. Epub 2022 Apr 8.
2
Tracking the Evolution of Non-Small-Cell Lung Cancer.跟踪非小细胞肺癌的演变。
N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.
3
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.局部突变多样性驱动非小细胞肺癌肿瘤内免疫异质性。
Nat Commun. 2018 Dec 18;9(1):5361. doi: 10.1038/s41467-018-07767-w.
4
Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.利用核流分选方法探索转移性肺腺癌的时空遗传异质性。
J Pathol. 2019 Feb;247(2):199-213. doi: 10.1002/path.5183. Epub 2018 Dec 28.
5
Multiregion sequencing and subclonal analysis reveal intratumoral heterogeneity in esophageal squamous cell carcinoma.多区域测序和亚克隆分析揭示食管鳞癌肿瘤内异质性。
J Cancer Res Ther. 2021 Jul;17(3):756-763. doi: 10.4103/jcrt.jcrt_270_21.
6
Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.基于肿瘤内遗传异质性的原发性和转移性结直肠癌的亚克隆基因组结构。
Clin Cancer Res. 2015 Oct 1;21(19):4461-72. doi: 10.1158/1078-0432.CCR-14-2413. Epub 2015 May 15.
7
Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.非小细胞肺癌中位于D13S171位点(BRCA2)的等位基因不平衡及p53改变与肿瘤动力学和染色体不稳定性(非整倍体)的关联
Cancer. 2000 Nov 1;89(9):1933-45. doi: 10.1002/1097-0142(20001101)89:9<1933::aid-cncr9>3.3.co;2-4.
8
Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer.表观遗传改变与非小细胞肺癌中的肿瘤突变负担有关。
J Immunother Cancer. 2019 Jul 26;7(1):198. doi: 10.1186/s40425-019-0660-7.
9
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.原发性肺癌和远处转移灶的多组学分析揭示,免疫抑制是具有转移可塑性的肿瘤细胞的共同特征。
Genome Biol. 2020 Nov 4;21(1):271. doi: 10.1186/s13059-020-02175-0.
10
Intratumoral heterogeneity and genetic characteristics of prostate cancer.前列腺癌的肿瘤内异质性和遗传特征。
Int J Cancer. 2020 Jun 15;146(12):3369-3378. doi: 10.1002/ijc.32961. Epub 2020 Mar 25.

引用本文的文献

1
Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies.染色体不稳定性驱动的癌症进展:与肿瘤微环境的相互作用和治疗策略。
Cells. 2023 Nov 26;12(23):2712. doi: 10.3390/cells12232712.

本文引用的文献

1
Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination.预测同侧胸膜播散的非小细胞肺癌患者癌症特异性生存的列线图的开发与外部验证
Front Oncol. 2021 Jul 19;11:645486. doi: 10.3389/fonc.2021.645486. eCollection 2021.
2
Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds.基于肿瘤免疫表型特征的高通量筛选以发现联合免疫治疗化合物。
Sci Adv. 2021 Jan 22;7(4). doi: 10.1126/sciadv.abd7851. Print 2021 Jan.
3
Whole-genome doubling confers unique genetic vulnerabilities on tumour cells.
全基因组加倍赋予肿瘤细胞独特的遗传脆弱性。
Nature. 2021 Feb;590(7846):492-497. doi: 10.1038/s41586-020-03133-3. Epub 2021 Jan 27.
4
PyClone-VI: scalable inference of clonal population structures using whole genome data.PyClone-VI:利用全基因组数据对克隆群体结构进行可扩展推断
BMC Bioinformatics. 2020 Dec 10;21(1):571. doi: 10.1186/s12859-020-03919-2.
5
Pervasive chromosomal instability and karyotype order in tumour evolution.肿瘤进化中的普遍染色体不稳定性和核型顺序。
Nature. 2020 Nov;587(7832):126-132. doi: 10.1038/s41586-020-2698-6. Epub 2020 Sep 2.
6
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
7
Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival.对于特殊胸膜播散病变的肺腺癌,可以考虑采用观望治疗策略,低基因组不稳定性与更好的生存相关。
Ann Surg Oncol. 2020 Oct;27(10):3808-3818. doi: 10.1245/s10434-020-08400-1. Epub 2020 Apr 1.
8
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.全基因组加倍与癌症进化中有害突变积累之间的相互作用。
Nat Genet. 2020 Mar;52(3):283-293. doi: 10.1038/s41588-020-0584-7. Epub 2020 Mar 5.
9
A clonal expression biomarker associates with lung cancer mortality.一种克隆表达生物标志物与肺癌死亡率相关。
Nat Med. 2019 Oct;25(10):1540-1548. doi: 10.1038/s41591-019-0595-z. Epub 2019 Oct 7.
10
Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids.人类结直肠癌细胞类器官中的持续染色体不稳定性和核型演化。
Nat Genet. 2019 May;51(5):824-834. doi: 10.1038/s41588-019-0399-6. Epub 2019 Apr 29.